Provided by Tiger Trade Technology Pte. Ltd.

Anavex Life Sciences

2.02
-0.3400-14.41%
Post-market: 2.030.0100+0.50%18:42 EDT
Volume:2.96M
Turnover:6.19M
Market Cap:187.20M
PE:-13.97
High:2.38
Open:2.38
Low:1.89
Close:2.36
52wk High:10.38
52wk Low:1.89
Shares:92.67M
Float Shares:91.12M
Volume Ratio:3.12
T/O Rate:3.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1446
EPS(LYR):-0.5438
ROE:-12.80%
ROA:-9.70%
PB:1.66
PE(LYR):-3.71

Loading ...

Anavex Life Sciences Holds Annual Shareholder Meeting; 54,239,204 Shares Represented by Proxy

Reuters
·
Sep 29

Anavex says stockholders elect all company director nominees

TIPRANKS
·
Sep 24

ISS Backs Anavex Board Slate, Urges “for” Votes on All Six Director Nominees Ahead of Annual Meeting

Reuters
·
Sep 24

Anavex Life Sciences Held Annual Stockholders Meeting

Reuters
·
Sep 24

Anavex Stockholders Elect All of the Company’s Director Nominees at 2026 Annual Meeting

THOMSON REUTERS
·
Sep 24

Press Release: Anavex Stockholders Elect All of the Company's Director Nominees at 2026 Annual Meeting

Dow Jones
·
Sep 24

PVG Asset Management announces plan for first 100 days at Anavex

TIPRANKS
·
Sep 18

PVG says Glass Lewis recommends Anavex shareholders vote for two nominees

TIPRANKS
·
Sep 18

Glass Lewis Recommends Anavex Stockholders to Vote for PVG’s Director Nominees

Reuters
·
Sep 18

Pvg Asset Management: Glass Lewis Recommends for Pvg Nominees Hogue, Kolbert; Against Incumbents Ma, Van Der Velden

THOMSON REUTERS
·
Sep 18

Pvg Asset Management: Glass Lewis Recommends Avxl Stockholders Vote Gold Universal Proxy Card at Sept 24, 2026 Meeting

THOMSON REUTERS
·
Sep 18

ISS Backs Anavex Board Slate, Urges Vote for All Six Director Nominees in Proxy Fight with PVG

Reuters
·
Sep 14

Anavex Says FDA Grants Meeting Request on Adding Pediatric Patients to Phase 3 Rett Syndrome Trial of Blarcamesine

Reuters
·
Sep 10

PVG Calls for Replacing Anavex Board, Hiring "Experienced" CEO

Reuters
·
Sep 10

Pvg : Calls for Replacement of Anavex Board and Hiring of "Experienced" CEO

THOMSON REUTERS
·
Sep 09

Pvg: We Do not Believe Anavex Can Obtain Funding They Need to Advance Blarcamesine Phase 2B/3 Trial with Existing Team

THOMSON REUTERS
·
Sep 09

Anavex Schedules Sept. 9 Investor Call to Outline Clinical Development Strategy and Priorities

Reuters
·
Sep 08

PVG calls for ‘meaningful board refreshment’ at Anavex

TIPRANKS
·
Sep 04

Pvg Asset Management- Nominates Six Director Candidates for Anavex Board

THOMSON REUTERS
·
Sep 04

Anavex Life Sciences Regains Nasdaq Compliance After Filing Quarterly Reports

MT Newswires Live
·
Sep 03